VCRE
Vicore Pharma Holding AB
9.30$
-1.1%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures per share in SEK.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 24 | Q1 25 | Q2 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|
| 0.02 | 0.00 | 0.01 | 0.00 | 0.00 | 0.01 | 0.02 | |
| 0.02 | 0.00 | 0.01 | 0.00 | 0.00 | 0.01 | 0.02 | |
| 0.35 | 0.34 | 0.42 | 0.40 | 0.36 | 0.42 | 1.54 | |
| 0.07 | 0.06 | 0.06 | 0.08 | 0.08 | 0.12 | 0.32 | |
| 0.42 | 0.39 | 0.48 | 0.48 | 0.44 | 0.54 | 1.86 | |
| -0.40 | -0.39 | -0.47 | -0.47 | -0.44 | -0.53 | -1.84 | |
| 0.00 | 0.11 | 0.06 | 0.03 | 0.00 | 0.00 | 0.08 | |
| -0.36 | -0.48 | -0.49 | -0.49 | -0.39 | -0.51 | -1.79 | |
| -0.36 | -0.48 | -0.49 | -0.49 | -0.39 | -0.51 | -1.79 | |
| – | – | -0.43 | -0.46 | -0.38 | -0.51 | -1.70 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.